# Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

> **NCT00458653** · PHASE1 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 45 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** Dendritic Cell Tumor Fusion

## Key facts

- **NCT ID:** NCT00458653
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2012-04
- **Final completion:** 2020-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458653, "Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00458653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*